Introduction 2D ultrasound image quality and automated quantification methods have improved in recent years. Quantification of cardiac dimensions is important to screen and monitor cardiac and extra-cardiac fetal conditions. We assessed feasibility and reproducibility for fetal ventricular measures using 2D echocardiography and compared measures to reports using other modalities. Methods Fetal hearts were scanned using an apical or basal fourchamber view. Left and right ventricular (LV and RV) mass and end-diastolic volumes (EDV) were measured by manual contouring of endo and epicardium using TomTec Image Arena 4.6 in end-diastole. Intraclass Correlation Coefficients (ICC) were used to estimate intra-and inter-observer agreement. Nomograms were created from smoothed centiles of mass and volume measurements, constructed using fractional polynomials after logtransformation. Results were compared to those from previous studies using other modalities identified from literature review. Results 294 scans from 146 fetuses were included from 15 + 0 to 41 + 6 weeks of gestation. 7% of scans were unanalysable and intraobserver variability was good (ICC for LV and RV mass 0.97 (0.87-0.99) and 0.99 (0.95-1.0) respectively). There was good agreement with 3D estimates of mass up to 28 weeks of gestation, after which 2D measurements were in better agreement with previous results from neonatal cardiac MRI. There was good agreement with 4D volume estimates for the LV. Conclusion Current state-of-the-art 2D echocardiography platforms appear to provide accurate, feasible and reproducible ventricular mass and volume measures across a wide range of gestations. In certain circumstances, such as extremes of gestation, 2D ultrasound may be the modality of choice.
Introduction The aim of this study was to assess prenatally the fetuses of pregnant women exposed to Zika virus (ZIKV) areas for microcephaly, intracranial and other abnormalities and monitor their head circumference size at birth. Methods All pregnant women (symptomatic or not) that reported history of travel to Zika affected areas during their pregnancy were referred to the Fetal Medicine Unit at Royal Free Hospital for surveillance. They had serial growth scans every 4 weeks from the date of first referral for assessment, to assess head circumference (HC) measurement and evaluate fetal brain and limb anatomy. Blood samples were taken for ZIKV only in those symptomatic. Postnatally, the HC of the babies was measured to identify those with possible microcephaly. A total of 49 pregnant women were included in the study. 23 women are still pregnant and the fetuses have not been assessed postnatally yet.
Results The final number of women assessed was 22 (four miscarriages). The most common travel destination was Mexico (33.3%, 7 women). Three women were symptomatic. Only one woman tested positive for ZIKV infection. Only one fetus presented with microcephaly prenatally but was negative for ZIKV IgM. Four newborns had a HC below the 5th centile at birth. Conclusion We have identified only one positive ZIKV case and no fetal abnormalities have been identified postnatally in those women that delivered. The four newborns that were born with HC measurements below the 5th centile appear to be healthy postnatally.
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Improving the antenatal detection of fetal growth restriction: An audit of missed opportunities Morgan, L 1 ; Cartmill, J Introduction To demonstrate that renal vein thrombosis is a not uncommon finding at autopsy examination of late intra uterine foetal death. It may be overt, with haemorrhagic infarction and propagation of thrombus into the vena cava or may not be found on careful gross examination but be clearly identified on microscopic histological examination. It is associated with chorionic vein and chorionic artery thrombosis. It is a cause of thromboembolism to the foetal circulation and with chorionic vessel thrombosis can be associated with cerebral infarction and occlusive limb ischaemia.
Results Four of the infants were stillborn with varying degrees of maceration, one was an early neonatal death. Two babies had external manifestations of thromboembolism: One had gangrene of the right forearm, another (the neonate) of the head and face. Two babies had bilateral thrombosis with hemorrhagic infarction of one kidney. Three had histological evidence of disease only, not seen on gross examination. Four had chorionic artery thrombosis and three vein thrombosis identified on histological examination of the placenta.
Conclusions A hypercoagulable state is a disease association of mother and fetus. In the foetal circulation, polycythaemia and vascular stasis associated with IUGR, maternal diabetes or chromosomal aneuploidy, can predispose to thrombosis within the foetal and placental compartments. Foetal death, perinatal stroke or cerebral palsy may be the result. The pathophysiology of renal vein thrombosis is complex and may present at different stages. Fibrinolysis is the mechanism of resolution, detachment of thrombus, the origin of thromboembolism. Postmortem lysis may also obscure the embolic event.
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The Peninsula Pre/Perinatal Twins Research Bank (PTRB): Facilitating research into epigenetic and transcriptional variation in twins Knight, B 1 ; Taylor, MT Introduction Monozygous twins share a common DNA sequence but are often discordant for disease. They are ideal for studying the potential role of the intrauterine environment in development, and its influence on genomic variation. The Peninsula Pre/ Perinatal Twins Research Bank (PTRB) was set up to provide a secure, ethically approved infra-structure to collect and store biological samples from twin pregnancies to enable genomic research. We aim to test the potential of the Peninsula Pre/Perinatal Twins Research Bank (PTRB) to facilitate studies on the role and consequences of (epi)genomic variation arising during fetal development from a variety of tissues. Methods Women with planned LSCS delivery for twin pregnancies were recruited at pre-op visit. Blood samples were obtained from both parents for DNA analysis and serum/plasma storage. Cord/placenta tissue and cord blood for DNA extraction was obtained from each twin at delivery. Additional meconium samples/buccal swabs/heel prick blood spots were obtained during routine post-natal care and stored. Associated routinely collected obstetric data was recorded.
Results 20/21 (95%) women and 18/20 (90%) fathers were recruited and provided blood samples over a 12 month period. Post-delivery twin tissue for genomic analysis was obtained from all 40 twins. Conclusion This inaugural project enabled assessment of the PTRB infrastructure and feasibility of recruitment and sample collection during routine clinical care. We established an initial cohort of twin pregnancies specifically designed for molecular epidemiology. This together with our ability to store and manage samples/data transferred from other relevant projects will allow us to facilitate future epigenetic study.
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A hemizygous mutation in FOXP3 gene (responsible for IPEX syndrome) resulting in recurrent X-linked fetal hydrops -a case report Background Fetal hydrops carries a wide differential of underlying pathology with a reported 18% of unknown origin, leaving a guarded prognosis for future pregnancies. IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome is a monogenic primary immunodeficiency syndrome of X-linked recessive inheritance due to FOXP3 gene mutations resulting in diabetes, hypothyroidism, diarrhoea and dermatitis with neonatal and childhood mortality. We present a rare cause of fetal hydrops in the context of IPEX syndrome.
Case A 28-year-old in her first pregnancy underwent a 20 + 6/40 anomaly ultrasound revealing fetal hydrops and an increased MCA peak systolic velocity. Fetal blood sampling confirmed anaemia, however demise occurred following an intra-uterine transfusion. Routine postmortem, array CGH, infection and antibody screening were normal. In her second pregnancy with a different partner, serial ultrasounds following dating scan were normal. The 20 + 3/40 anomaly ultrasound detected fetal hydrops with no evidence of fetal anaemia. Invasive testing was declined and the patient opted for medical interruption of pregnancy at 25 + 3/40 due to rapid fetal hydrops progression and poor prognosis. Linkage analysis showed both male babies had inherited the same maternal X chromosome supporting an X-linked pattern of inheritance. Subsequent whole exome sequencing demonstrated a hemizygous mutation within the FOXP3 gene in the patient and both babies. Conclusion In the context of male fetal hydrops, FOXP3 gene mutations are a differential for currently 'unexplained' cases. Counselling regarding this X-linked inheritance pattern involves strategies such as fetal sexing on maternal blood, invasive testing, pre implantation genetic diagnosis and free fetal DNA testing in future pregnancies.
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Spina bifida: Our experience over 15 years in the Royal London Hospital Vaikousi, E 1 ; Spaan, J 1 ; Aquilina, J 1 ; Gupta, M Introduction Spina bifida remains the commonest neural tube defect (NTD), with prevalence in the United Kingdom of 0.2 per 1000 live births. Folic acid has reduced incidence significantly, but its multifactorial nature means that it still occurs; it may persist in a folate-replete population.
Methods We present our experience of 53 cases of spina bifida diagnosed antenatally in our hospital over the last 15 years. We examined ultrasound and MRI reports as well as records of postrepair complications and long term disability. Of the 53 couples, 20 decided to continue with the pregnancy. MRI was requested in 11/20. Results Nineteen babies were born alive, with 1 neonatal death due to extreme prematurity. Two were stillbirth due to additional congenital defects, 3 had late miscarriages and the rest underwent termination of pregnancy. MRI was implemented since 2010 (in 11/20 cases) and its findings agreed with level of defect and severity of ventriculomegaly on ultrasound. MRI also detected additional defects including talipes, agenesis of corpus callosum and absence of cerebellum. 5/18 live babies had defects not detected prenatally, including two with imperforate anus and one with exomphalos. All had surgical repair and shunt for hydrocephalus postnatally.
Recorded long-term follow-up showed ongoing problems in 8, including bladder and lower limb sensory and motor dysfunction. Conclusion In our experience ultrasound proved accurate in diagnosis of the level of defect but the introduction of MRI in the investigative work-up proved a useful adjunct in terms of prognostic assessment of the lesions.
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Closing the gap between process-driven medicine and patient-driven medicine Wilkins, S 1 ; Fairclough, S 1 ; Cunningham, S
Moving the NHS to a more patient-centred care is one of the targets of the NHS Five Year Plan. Engaging and empowering patients to improve their experience and outcomes was emphasised in the Berwick response to the Francis report into Mid-Staffs as a way of balancing the compassionate and technical aspects of care. Providing detailed patient information can be challenging, however we sought to empower patients with fetal medicine concerns by involving them in this process. Information for patients by patients giving them a stronger role in their own health experiences. We created information leaflets focused on frequently asked questions relevant to conditions and published these alongside patient experience videos discussing how they managed the practicalities and stress throughout pregnancy and after. This has been done with the aim of using multiple media to close the information gap and provide advice for patients in different modalities. We audited the information in the video by using feedback forms given to relevant patients to confirm if they adequately addressed their concerns. Empowering patients with knowledge about their own medical conditions, allowing them to be more involved in their own care is seen as a cornerstone of patient centred care and been shown to improve outcomes. The use of hospital websites can be a key area to demonstrate patient engagement. It is important to embrace this change in culture and engage with patients in ways they would best respond to, such as information leaflets, online videos and potentially the possibility of mobile apps.
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Predictors of good outcome in cystic hygroma Schaler, L; Doddy, F; Wallis, L; Kennelly, M; Lynch, C; Martin, A; Regan, C; Daly, S Coombe Women and Infants University Hospital, Dublin, Ireland
The objective of this study was to predict factors associated with good outcome among cases of Cystic Hygroma (CH). This was a prospective cohort study of all cases diagnosed from July 2014 to July 2016. There were 59 cases of CH examined giving an incidence of approximately 1:288. There were 46 karyotypes obtained mostly by CVS (76%). The karyotype was Trisomy 21 in 19 cases (41%), 45X in 5 cases (10.8%), Trisomy 18 in 5 cases (10.8%), Trisomy 13 in 4 cases (8.8%), Triploidy in 1 case and normal in 12 cases (26%). The outcomes were termination of pregnancy in 28 cases (47%), IUD 11 cases (18.6%), early pregnancy loss 3 (5%) and one NND. There were 5 cases of a normal baby being delivered (8.4%) and there are 7 cases ongoing of which 5 are presumed normal with one Trisomy 21 and one hypoplastic right heart syndrome. An evaluation of the diagnostic scan revealed a CH confined to the head and neck in 16 cases (27%). The mean transverse measurement was 6.29 SD (4.0) mm. The mean value for the transverse measurement in the normal group was 4.0 mm SD (1.6), compared to a mean value of 6.29 mm in the overall population P < 0.0001. Using a normal outcome as the dependent variable the extent of the cystic hygroma was more important than the transverse measurement (P = 0.02).
Overall the outcomes for CH in our population were similar to published reports. We identified the extent of the CH as an additional outcome variable. Introduction Pre-test counselling for fetal aneuploidy screening is an essential prerequisite before an informed choice can be made by patients, in particular where increased testing options are available. Our objective was to evaluate the role of pre-test counselling when multiple options for fetal aneuploidy screening exist. Methods A prospective cohort study of patients opting for fetal aneuploidy screening in the first trimester was performed over 3 months. All patients were questioned regarding motivating factors, preferences for screening, and limiting factors influencing patient choices. Results A total of 242 patients received detailed pre-test counselling regarding different forms of screening, including FTS (first trimester screening using nuchal translucency with serum markers), Harmony (non-invasive prenatal testing of fetal DNA for aneuploidy) and Panorama (non-invasive prenatal testing of fetal DNA for aneuploidy and DiGeorge). Panorama NIPT was the most popular screening option, with 210 of 242 patients ultimately choosing this option. 56% (23/41) of patients originally scheduled for Harmony NIPT and 45% (5/11) of FTS patients switched to a different screening option following pre-test counselling. Reasons to switch from one test to another include cost of screening, detection rate, range of conditions being tested, wait time for results and gestational age. Conclusion The vast majority of patients who decided to switch tests (78%) chose Panorama NIPT as the alternative, following pre-test counselling. These changes in patient choices highlight the critical importance of pre-test counselling in fetal aneuploidy screening and emphasise that appropriate resources must be provided for this aspect of the screening process.
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Fetal telemedicine pilot -a study of clinical stakeholder acceptance of a tele-ultrasound innovation linking a rural district general hospital with a fetal medicine unit at a major teaching hospital in northern England Introduction The GENESIS study investigated a range of clinical, demographic and fetal ultrasound parameters in the development of a risk evaluation tool for Caesarean Delivery (CD) in nulliparous women at term. We evaluated the role of examining umbilical artery Doppler (UA Doppler) and whether there is a correlation with non-reassuring fetal testing and mode of delivery in healthy nulliparous patients? Methods The Genesis Study was a prospective multi-center, blinded observational study in which a total of 2336 women with a vertex presentation, were recruited across seven obstetric units in Ireland. Participants had an ultrasound scan and a clinical evaluation performed between 39 +0 and 40 +6 weeks of gestation.
One centre elected to assess UA Doppler. Women and clinicians were blinded from all the ultrasound details to reduce bias from pre-existing knowledge. Information was disclosed to clinicians when the EFW >5000 g or there was a biophysical profile <8/8. All patients delivered within 10 days of the ultrasound scan. Abnormal UA Doppler was defined as AEDF or UA pulsatility index (PI) >95th centile.
Results The UA Doppler was recorded in 587 patients and no differences were noted in non reassuring fetal testing or mode of delivery when comparing patients whose UAPI >95th centile to those with a UAPI <95th centile. There was 1 case of AEDF in this group and the details were disclosed to the clinicians. Conclusion In healthy nulliparous patients with appropriately grown fetuses there appears to be no role in evaluating UA Doppler at term.
P.FM.16
Cerebroplacental ratio in recurrent reduced fetal movements: Evidence for worsening fetal hypoxemia Binder, J Methods A unicentre prospective study spanning 14 months was conducted in a tertiary-referral obstetric hospital. All women attending for a method of DSS were invited to participate in the patient questionnaire.
Results Of 537 women attending for DSS, 300 women completed the questionnaire, patient uptake of 56%. The test of choice was FTS for 13.6% (n = 41), NIPT for 66.3% (n = 199) and not disclosed in 20% (n = 60). Patient demographics attending for trisomy DSS 73% (n = 220) were white Irish; mean age of participants was 36.5 years; 85% (n = 255) of women had a tertiary education; 60% (n = 181) of women classed themselves as religious with 77% (n = 145) predominance Catholic faith. If cost were equivocal 81% (n = 243) would have the same test, 1.3% (n = 4) would opt for the alternative test and 17.7% (n = 53) did not respond. Conclusion The reasons for attending for DSS were similar in both the FTS and NIPT groups. Contrary to our hypothesis cost was not a major contributor in patient choice. However, the majority of our patients were from a higher socioeconomic group which may have influenced their perception of cost.
Introduction Up to 10% of births <32 weeks of gestation develop cerebral palsy and 50% have other neurodevelopmental sequelae. Infection/inflammation is implicated in the aetiology of preterm birth (PTB) and in the pathophysiology of associated brain injury. This study aimed to see if alterations in brain development begin prior to delivery using magnetic resonance spectroscopy (MRS), a noninvasive way of assessing the metabolic profile of tissue in vivo.
Methods Six patients at high risk of PTB <32 weeks: preterm rupture of membranes or >50% risk of delivery derived from an algorithm based on cervical length and fetal fibronectin were recruited between 20 and 32 weeks of gestation and underwent a fetal MRI on a 1.5T scanner. 24 control cases were used who had undergone an MRS <32 weeks. Conventional images were obtained followed by MRS at an echo time of 136 ms. Spectroscopy data was post-processed using the Jmrui software package to generate NAA:Cho, NAA: Cr and Cho:Cr ratios. ANCOVA statistical analysis was performed using SPSS.
Results Gestational age at MRI for the preterm group was median 25 + 0 (range 20 + 6-31 + 1) and median 27 + 3 (range 21 + 4-31 + 6) for the control group. There was no difference in metabolite ratios between control and preterm groups (NAA:Cho P = 0.83 NAA:Cr P = 0. Case A primigravid presented with reduced fetal movements at 27 + 2 weeks. Ultrasound scan (USS) demonstrated a right sided intra-abdominal mass in the fetus measuring 9 9 6 9 6 cm. There was moderate pleural effusion and middle cerebral artery peak systolic velocity (MCA-PSV) was above 1.5MoMs, suggesting fetal anaemia. An intrauterine transfusion of 60mls of red cells was performed (fetal haemoglobin 3.1 g/dl). Two days later, MCA-PSV remained high, suggesting further bleeding and thrombocytopenia, with scalp oedema and reduced fetal movements. Further transfusion was thought unlikely to be beneficial and delivery was performed by caesarean section. The baby was delivered with no respiratory effort or heart rate. Clamping of the cord was delayed in view of the anaemia and he was intubated at 2 minutes of life. Packed red cells and platelets were transfused. Ventilation was difficult due to the mass and emergency laparotomy revealed a non-resectable mass in the right lobe of the liver. Abdominal tension was reduced by closing with a goretex patch and ventilation immediately improved. The baby required intensive care and multiple transfusions of blood and platelets. Initial MRI scan was inconclusive but a subsequent USS identified a large vessel feeding the mass, consistent with haemangioendothelioma, confirmed by later CT. At 37 weeks he underwent hepatic artery ligation as the mass remained unresectable. Non-invasive ventilation was weaned and breast feeding was established. He was discharged home 44 + 3 weeks of gestation. Conclusion Liver tumours presenting antenatally are extremely rare. This is the first report of survival of an extremely preterm neonate with hepatic haemangioendothelioma. 
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Safety and acceptability of surgical termination of pregnancy for fetal anomaly within an independent sector termination of pregnancy service Callaby, H 1 ; Lohr, P 2 ; Fisher, J Introduction To describe the safety and acceptability of surgical termination of pregnancy for fetal anomaly (TOPFA) within an independent sector termination of pregnancy service in Britain.
Methods Non-identifiable demographic, treatment, and complications data for women undergoing TOPFA at British Pregnancy Advisory Service (BPAS) between 1 Jan 2015 and 31 Mar 2016 were extracted from existing databases. Anonymous feedback was obtained using a structured questionnaire. Descriptive data were generated using Excel.
Results In total, 389 women were treated along a specialised care pathway within routine surgical termination of pregnancy lists. Average age was 38 years (range 17-48), 61% were parous; 20% had a prior termination of pregnancy, 31% a prior miscarriage or ectopic. Median gestational age was 14 weeks + 6 days (range 10 + 2-23 + 5). Indications for TOPFA were diagnosed chromosomal/genetic anomaly (64%), structural anomaly (31%), suspected chromosomal and/or structural anomaly (4%), and not recorded (1%). Time from referral to treatment averaged 6 days (range 1-22 To ascertain whether prenatal mobility of the atrial septum in babies with transposition of the great arteries (TGA) is associated with need for emergency atrial septostomy. Methods An eight-year retrospective cohort of pregnancies with prenatally diagnosed TGA from the Wessex Fetal Medicine unit. The appearance of the atrial septum during third trimester echocardiography was classified as normal or redundant: bulging >50% of the way across to the left atrial free wall, flat: the angle between the septum primum and the rest of the septum <30% and fixed: little movement of septum, as previously described (Wilson et al, Journal of the American Society of Echocardiography 1990). This was correlated with need for emergency septostomy.
Results 33 babies had an antenatal diagnosis of simple TGA. We had complete data in 24 babies. The atrial septum was classified as normal in 50.0% (n = 12). The abnormal septal morphology group (n = 12) was equally distributed between the three categories described. 17 (70.8%) babies had septostomies; 13 (76.4%) within 24 hours of birth. In emergency septostomy subgroup, the septum was normal in 30.7% (n = 4), flat in 30.7% (n = 4), fixed in 23.0% (n = 3) and redundant in 15.3% (n = 2).
Three babies with a fixed (75.0%), two babies with a redundant (50.0%) and all babies with a flat septum required an emergency septostomy.
Conclusion There is a good correlation with an abnormal atrial septum and the need for emergency septostomy in our cohort. However further research into improving the positive predictive value of antenatal assessment is needed.
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Should all newborn with antenatal diagnosis of polyhydramnios have nasogasteric tube patency testing after delivery? A service review of approach to diagnose tracheo-oesophageal fistula in neonates born to mothers with polyhydramnios Singh, NIntroduction To evaluate if a policy of passage of Nasogastric tube (NGT) in infants born with antenatal diagnosis of polyhydramnios has improved the detection rate of tracheooesophageal fistula AE oesophageal atresia (TOF AE OA).
Methods In this retrospective study we identified all cases of antenatally diagnosed polyhydramnios between January 2009 -December 2014. As per policy, NGT patency test should have been performed after delivery in all cases. We identified the infants operated on for TOF AE OA from computerised discharge summary and theatre operating list. For the purpose of the study we have only included cases which had maternity scans and delivered in our tertiary centre. Introduction Abnormal placental cord insertions (PCI) including velamentous cord insertion (VCI) and marginal cord insertion (MCI) have been associated with adverse pregnancy outcomes including small-for-gestational-age (SGA) infants. We systematically reviewed and meta-analysed studies of abnormal PCI and the associated adverse outcomes. Methods Embase, Medline, CINAHL, Scopus, Web of Science and Cochrane Databases were searched in September 2016 (from inception to September 2016). Potentially eligible studies were reviewed by two authors independently. The quality of included studies was assessed using the Newcastle-Ottawa Quality Assessment Scale. Summary risk ratios with 95% confidence intervals were calculated. Results Meta-analysis of two studies showed a statistically significant increased risk of SGA infants with VCI (pooled RR, 2.38; 95% CI, 2.25-2.52, P < 0.00001) and MCI (pooled RR, 1.63; 95% CI, 1.57-1.69, P < 0.00001) compared to normal PCI. Four studies were meta-analysed for the outcome emergency caesarean section (CS) and showed a statistically significant increased risk with VCI (pooled RR, 2.86; 95% CI, 1.56-5.22, P = 0.0006) and MCI (pooled RR, 1.39; 95% CI, 1.35-1.44, P < 0.00001). MCI and VCI were combined as abnormal PCI, showing similar findings. Meta-analysis of two and four studies respectively, showed a statistically significant increased risk of SGA (pooled RR, 1.78; 95% CI, 1.72-1.83, P < 0.00001) and emergency CS (pooled RR, 1.48; 95% CI, 1.44-1.52, P < 0.00001) for abnormal PCI compared to normal PCI with no evidence of significant heterogeneity (I 2 < 50%, P > 0.05).
Conclusion
The available evidence suggests an association between abnormal PCI and adverse pregnancy outcomes, with VCI having higher risk compared to MCI.
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Placental and umbilical cord morphometry of pregnancies with small-for-gestational-age infants Multiple factors contribute to infants being small-forgestational-age (SGA), including placental and umbilical cord (UC) abnormalities. Research focuses on timely antenatal detection of SGA, to reduce associated risks of perinatal mortality and morbidity. We aimed to examine different morphological characteristics of the placenta and UC, focussing on pregnancies with SGA infants. This prospective cohort study examined 1005 placentas from consecutively-delivered singleton pregnancies in a tertiary centre. Standardised images of each placenta were taken. Measurements on gross examination included placental weight and thickness; umbilical cord length, diameter and handedness. Distance from placental cord insertion site to placental margin, length and breadth of the placenta and placental chorionic surface area were measured digitally using ImageJ software. Birthweight and gestational age were recorded. Classification and regression models were used to identify the best subset of measurements to correctly classify infants as SGA (<10th centile). Overall, 141 (14%) infants were SGA. A regression model with maternal age, placental weight, surface area and birthweight to placenta weight ratio correctly classified 98% of infants >10th centile and 47% of infants <10th centile. Of the potential antenatal measurements, diameter of UC (placental and fetal ends), and distance from placental cord insertion to placental margin were statistically significant (P < 0.05) predictors after adjusting for maternal age, with smaller diameters and shorter distances associated with increased odds of SGA. SGA infants can be identified using placental and UC morphometry. Further research on antenatal detection may improve our understanding of the pathophysiology and contribute as predictors for SGA.
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Prolapsed patent urachus found at 13 weeks of pregnancy A multigravida was referred after an umbilical cord cyst was seen during her 12 week nuchal translucency scan. Repeat scan at 13 + 1 weeks confirmed presence of an 11 9 12 mm cystic structure at the base of the umbilical cord connecting to the enlarged fetal bladder. The fetus was male and NIPT was negative. At 16 + 1 weeks the cyst had enlarged further with normal liquor and normal kidneys. At 20 weeks of gestation, the bladder remained large but there was no obvious keyhole sign and kidneys remained normal. The cyst was larger than the fetal head at this point. However, at 32 + 6 weeks, the cyst had collapsed. The infant was delivered following induction of labour at 38 + 1 weeks. A red mucosal mass with a visible lumen protruded from an abdominal wall defect, similar to an exomphalos. Clear fluid could be expressed from the lumen. The appearances suggested rupture of the cord cyst with prolapsed bladder mucosa. Cystoscopy revealed a tubular bladder with normal mucosa, and normally sited ureteric orifices. The scope passed into an inflamed region at the dome and then through the lumen at the umbilicus. Following excision of the sac, the prolapsed mucosa was excised and bladder closed in layers. An umbilicus was reconstructed and following excellent postoperative recovery the neonate was discharged home at 6 days with normal bladder function. The final diagnosis was of a prolapsed, persistent urachus with leakage of urine into the umbilical cord causing cystic appearance and resultant failure of closure of the abdominal wall.
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Late karyotyping during pregnancy: What should we tell our patients regarding success rate and pregnancy complications? Shakeel, F; Mousa, T; Cresswell, L University Hospital of Leicester, Leicester, UK Introduction To examine the success rate and pregnancy complications among pregnant women who had late karyotyping. Methods We carried out a retrospective analysis of all pregnant women who had karyotyping after 32 weeks of gestation between 2006 and 2016. Data were collected from the ultrasound, cytogenetic and maternity databases. Results We reviewed 100 pregnancies that underwent amniocentesis and chorionic villus sampling after 32 weeks during the study time period. The median gestational age was 32 weeks. Overall, 14 CVS and 86 amniocentesis procedures were performed. Indications for invasive testing were single system fetal abnormality in 68% of cases, multisystem fetal abnormalities in 20% of cases, 12% of cases had other indications. Premature rupture of membranes were reported in 3% of cases, preterm labour within two weeks in 14% of cases. There was no case of chorioamnionitis. The FISH results were reported in all 100 cases (100%). Culture failure rate was 0.07%. There was 100% concordance between the FISH and culture results. Fetal karyotype was abnormal in 13 cases (13%). Conclusion Third-trimester invasive testing is a good option for late karyotyping and should be considered for pregnant women who would like to avoid miscarriage. Patients should be counselled about risk of preterm labour and premature rupture of membranes. We propose that steroid injection for foetal lung maturity should be considered for all cases. Future work will be required to evaluate the success rate of micro-array in this cases. Methods This is a secondary outcome analysis in a randomised controlled trial of vitamin D supplementation in pregnancy (MAVIDOS trial) whose primary outcome were neonatal bone indices using dual energy x-ray absorptiometry (DXA). Maternal 25(OH) cholecalciferol was measured at 14 and 34 weeks of gestation. Participants with levels between 25 and 100 mmol/l were randomised prior to 17 weeks to either placebo or oral daily cholecalciferol 1000 IU. 3D ultrasound scans were performed at 20 and 34 weeks, where fetal femur volume (FV) was measured according to a previously validated method. Linear regression analysis between 25(OH) cholecalciferol and FV was performed in the study cohort irrespective of trial allocation. FV was compared between the placebo and intervention arms.
Results 367 women had FV data at 34 weeks of gestation. There was no significant correlation between 25(OH) cholecalciferol and FV. 188 women were randomised to placebo and had a mean FV = 4.7 ml; whereas 179 were assigned to daily cholecalciferol and had a mean FV = 4.6 ml (t-test, P = 0.18). There was no difference between the two groups in any of the constituent femoral measurements used to calculate FV. Conclusion Antenatal supplementation with 1000 IU cholecalciferol daily does not affect FV measurement in late gestation. These findings are consistent with the study's primary DXA outcome results, where a possible effect was demonstrated on bone mineralisation but not on bone size. Introduction The objectives were to identify antenatal ultrasound markers differentiating between complex and simple gastroschisis. Methods Longitudinal ultrasound examinations at four-weekly intervals were performed in isolated gastroschisis cases. Primary outcome was simple or complex gastroschisis. Biometry, polyhydramnios, intra-and extra-abdominal boweldiameters and the PI of the sma (superior mesenteric artery) were assed. The last measurements before delivery of the intra-and extraabdominal boweldiameters were used to compare mortality, time to full enteral feeding (TFEF) and length of hospital stay (LOS).
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Results Seventy-nine liveborns had simple and 19 had complex gastroschisis. Three intra uterine deaths occurred. There were 2 neonatal deaths in the complex and one in the simple group. TFEF and LOS were significantly longer in the complex group (P < 0.001, and P < 0.001, respectively). There was no correlation between biometry and the sma PI between both groups. In both groups the PI was significantly lower than in controls. Both intraand extra-abdominal boweldiameter were larger in complex cases and multilevel analysis showed a significant group main effect for both variables (P < 0.001 and P < 0.05, respectively). Identification of complex cases based on boweldiameter, remains, however, difficult. TFEF and LOS were significantly longer in cases with an intra-abdominal diameter >15 mm at the last measurement before birth (P = 0.009 and P = 0.013, respectively). Conclusion In both simple and complex groups the PI of the intra-and extra-abdominal sma is substantially lower than in controls, but this measurement does not differentiate between both groups. Only the intra-abdominal bowel diameter differentiates between simple and complex cases, although its predictive value is relatively low.
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The natural history of prenatally diagnosed fetal aneuploidy: A ten year series of expectantly managed cases in a large tertiary referral centre Prenatal diagnosis of chromosomal anomaly is associated with a high rate of termination and therefore many details regarding the expected antenatal course of those who chose to continue the pregnancy are relatively unknown. This study analysed the complications and outcomes associated with fetal aneuploidies in a single large tertiary centre. 500 prenatally diagnosed cases were identified between 2005 and 2015 from prospectively collected data in the Fetal Medicine Department, Rotunda Hospital. Chromosomal abnormalities included cases of Trisomy 21 (45.4%), Trisomy 18 (27.6%), Trisomy 13 (8%), Monosomy X (7.4%), Triploidy (3.8%) and others (7.8%). Of the 49.8% (n = 249) who were expectantly managed 59 (11.8%) miscarried, 43 (8.6%) suffered an intrauterine death and 118 (15.4%) achieved a live birth. There was a 38.14% Caesarean section rate with the indications attributed to maternal complications, maternal request and fetal distress (mostly in cases of Trisomy 21). Antenatal complications were recorded in 70 pregnancies, such as gross polyhydramnios (41), pre-eclampsia (5) and preterm prelabour rupture of membranes (3). The mean gestational age at time of delivery was 36 + 4 weeks (ranging from 26 to 42 + 2 weeks) and there were 29 neonatal deaths (24.6% of live births). The information gathered in this study gives insight into the natural history of common prenatally diagnosed aneuploidies and can be used to help guide counselling of patients regarding the prognosis and advise clinicians about the associated complications. Introduction To review the prevalence of clinically significant red blood cell antibodies among a cohort of pregnant women attending a tertiary maternity hospital and to assess their obstetric and neonatal outcomes. Methods A five year retrospective review of all pregnant women (including miscarriage, hydatidiform moles and ectopic pregnancy) who had an antibody screen in a tertiary referral centre between January 1 2011 and December 31 2015. Haematological, obstetric and neonatal data were identified from hospital databases. Ethical approval was obtained. Statistical analysis was carried out using SPSS v22. Results The prevalence of clinically significant antibodies among pregnant women screened was 0.53% (279/52 150). Anti-M (n = 77, 22.7%), anti-E (n = 70, 20.6%) and anti-D (n = 60, 17.7%) were the most common. Of the thirty four percent liveborn neonates (79/229) with a positive direct Coombs test (DCT), those associated with anti-D or anti-c had a lower mean gestational age (37.1 and 38.4 weeks) and haemoglobin level (123.8 and 146.2 g/L) at delivery compared to other antibodies. They were also more frequently admitted to the neonatal intensive care unit (22/33, 65% and 7/12, 58%) for phototherapy (23/34, 72% and 6/12, 50%) and exchange transfusion (11/34, 32% and 1/12, 8%). Conclusion In our population, the frequency of clinically significant antibodies was 1 in 187 pregnancies. As expected, the presence of rhesus (Rh) antibodies D or c was associated with worse perinatal outcomes requiring greater antenatal and postnatal care and treatment. Results support current practices for antibody screening and RhD prophylaxis. Introduction Our aim was to evaluate the effectiveness of intrauterine blood transfusion (IUT) to treat anemia in the surviving co-twin after single intrauterine fetal demise (sIUFD) in monochorionic diamniotic (MCDA) twin pregnancies. Methods A retrospective cohort study of MCDA twins with sIUFD and anemia in the surviving co-twin was conducted. Data was used from the national fetal therapy referral centre, the Leiden University Medical Center between 2005 and 2016. The outcomes of pregnancies treated with IUT were compared to expectantly managed pregnancies. Results In the study period, 247 pregnancies were seen with sIUFD. In 17 cases the surviving fetus appeared anemic based on middle cerebral artery Doppler examination. IUT was given in 6/ 17 surviving co-twins. We found no difference in co-twin mortality (3/6 (50%) versus 4/11 (36%)). Neonatal survivors in the IUT group all had normal imaging or an expected normal neurodevelopmental outcome. In the expectantly managed group, 2/7 survivors had severe cerebral injuries and 1 other neonate had non-severe anomalies on imaging. Conclusion IUT may improve neurodevelopmental outcome in anemic surviving co-twins after sIUFD. International multicentre collaboration is needed to obtain more data and preferably prospectively study this as yet unanswered clinical question.
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Spontaneous twin anaemia-polycythaemia sequence (TAPS) in monochorionic diamniotic twin complicated by selective intra-uterine growth restriction: A case report Dieh, A; Rana, N The Royal Oldham Hospital, Oldham, UK Twin to twin transfusion syndrome (TTTS) and Twin AnaemiaPolycythaemia Sequence (TAPS) can complicate monochorionic (MC) twin pregnancies. TAPS is less well-known of the two and is characterized by a marked difference in inter-twin haemoglobin without the discordant in liquor volume as in TTTS. We present a case of a set of monochorionic diamniotic twins complicated by selective intra-uterine growth restriction (sIUGR) and TAPS. Stage 1 TAPS were suspected at 33 weeks of gestation during a growth scan when middle cerebral artery MCA) doppler interrogation was performed. The fetuses were delivered by caesarean section at 34 weeks of gestation after corticosteroids cover. They have significantly discrepant haemoglobin levels at birth with the polycythaemia twin appeared plethoric as expected. It is unusual for TAPS to occur spontaneously. It is more common after laser ablation for TTTS (1-16%). A review of the literature shows that TAPS can occur spontaneously in 1-5% of MC twins. In most district general maternity units, monochorionic twins are scanned by sonographers who do not perform MCA doppler and current NICE guideline does not include the routine monitoring of MCA doppler. Therefore, TAPS may remain undetected during pregnancy. In cases where it is undetected and untreated, TAPS may lead to intrauterine fetal demise. In this case, increased surveillance was instigated due sIUGR which led to the suspicion of TAPS. Perhaps MCA dopplers should form part of the routine ultrasound assessments in all monochorionic twin pregnancy.
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The usefulness of fetal MRI for prenatal evaluation of fetal anomalies Doherty, E; Wyness, V; Fullerton, G; Crichton, L Aberdeen Maternity Hospital, Aberdeen, UK Introduction Evaluation of fetal anomalies by US can be limited. MRI is believed to provide greater accuracy and detail. It's usefulness in prenatal diagnosis was evaluated in this study. Methods Over a 36 month period August 2012 to August 2016, 47 patients received MRI to evaluate ultrasound diagnoses of fetal anomalies. US diagnoses included CNS anomalies, CDH, lung masses, limb, abdominal and urinary tract anomalies. Gestation at which MRIs were performed ranged from 21 to 35 weeks. Correlation between MRI findings and USS findings and postnatal diagnoses were examined to assess the value of each imaging modality. Results MRI changed the US diagnosis in 16 cases. 2 of the 5 cases of CDH diagnosed by MRI, the primary US diagnosis was CCAM. MRI refuted the US diagnoses of 5 brain abnormalities and 3 spinal abnormalities detected by ultrasound. MRI confirmed the US diagnosis of all 3 cases of spina bifida but provided more detailed information. MR provided more accurate assessment of urinary tract abnormalities than US. In 8 cases, the MRI was normal where ultrasound was not. MRIs consistent with US diagnoses provided clarity and additional detail. Conclusion Ultrasound is a cost-effective and safe screening tool however the information can be limited and doubtful. We suggest that fetal MRI is more informative than ultrasonography for the evaluation of suspected fetal anomalies which is particularly useful for prenatal counselling and postnatal treatment planning. Many women grieve for a pregnancy terminated for anomaly equivalent to stillbirth.
1 As a proxy for how many women made a close emotional connection, we investigated whether the terminated fetus was named and whether this was dependent on maternal history, gestation or type of termination. In our hospital, 128 pregnancies over six years were terminated using section E of the Abortion Act. Anomaly was suspected because of ultrasound findings (75, 58.6%), an abnormal screening test result (51, 39.8%), or medical history (known carrier) (2, 1.6%). Amniocentesis and CVS were performed for 28 (21.9%) and 19 (14.8%) pregnancies, respectively. Most terminations were medical (115, 89.8%), and five were preceded by feticide. Nearly half of parents named the fetus (62, 48.4%). There was no significant association of naming with gravidity, parity, or presence of a scan-detectable abnormality (all P > 0.10). Naming was more likely if termination was medical than surgical (61/115 versus 1/13, P = 0.002) and when diagnosis was by amniocentesis rather than CVS (P < 0.001). Six surgical terminations were following CVS. Named pregnancies were at a more advanced gestational age (median 130 days versus 90 days, P < 0.001). There was no association between naming a pregnancy and interval between suspicion of anomaly and termination. We believe that this adds useful information for those providing fetal medicine services in terms of the support women may require during the grieving process after termination for abnormality. Results An AC centile drop ≥40% (OR = 0.39, P = 0.023; 95% CI 0.17-0.88) and the CPR <10th centile (OR = 0.29, P = 0.002; 95% CI 0.13-0.63) were significant predictors of adverse outcome. AC centile drop and CPR centile were weakly correlated (r = À0.23, P = 0.006), indicating some shared variance. MLR showed that both AC centile drop ≥40% (0.41, P = 0.037; 95% CI 0.18-0.95) and the CPR <10th centile (0.31, P = 0.005; 95% CI 0.14-0.70) were independent predictors of adverse outcome (v 2 = 13.4, P = 0.001), and removing either from the model caused a significant drop in fit. Conclusion Analysis of both AC growth velocity and CPR could be used to better identify which SGA fetuses that are at increased risk of morbidity. If confirmed with larger numbers intervention could be better targeted.
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The 'dynamic' cervix -is it simply dynamic or truly incompetent? Thompson, MO; Opemuyi, I; Coker, A Barking, Havering and Redbridge University Teaching Hospital, Essex, UK
The rate of preterm birth (PTB), especially iatrogenic has increased in developed countries rather than reduced over time.
The evidence suggests that spontaneous PTB rates may be reduced by prophylactic progesterone in women with a history of previous preterm delivery and in those with a short cervical length identified by transvaginal sonography. However avoiding unnecessary medication during pregnancy is also desirable and although a dynamic cervix is reported to increase the risk of PTB, there is insufficient evidence. A dynamic cervix has been defined as one showing significant sporadic changes in length and appearance during a trans-vaginal ultrasound scan with shortening, funnelling or dilatation. Earlier studies report no changes in uterine contour or myometrial contractions that would indicate rapid increases in intra-uterine pressure as being responsible, therefore cervical weakness was implicated. This has however not been firmly substantiated although this may be expected because cervical remodelling is a dynamic process that involves complex biochemical and anatomical interplays, which ultrasound scanning as a test of competence does not allow for. We present two illustrative cases. The cases presented instigated a search for an evidence based approach to counselling and subsequent care. We sought to determine whether there is any clinical importance to be attached to dynamic change and therefore determine need for disclosure. The questions posed were; Is the dynamic cervix truly incompetent? What is the associated likelihood ration of spontaneous preterm delivery based on its occurrence? Should prophylactic therapy be instituted? Clinical evidence is currently limited. National guidance is needed.
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Case report of a prenatally diagnosed case of copy number loss for chromosome 5 long arm Gajree, S; Dumplacal, M shows a progressive decline with gestational age (GA). However, previous studies have reported that a proportion of pregnancies demonstrate worsening of the UtA Doppler. The aim of this study was to investigate the incidence of HDP according to the change in the UtA mean PI between the second and third trimester. Methods This cohort study included singleton pregnancies undergoing longitudinal UtA Doppler assessment in the second and third trimester. All the parameters were converted into centiles and multiples of the median (MoM) adjusting for GA. The study cohort was divided into 2 groups according to the change in the UtA Doppler between the second and third trimesters (decline or no change versus increase in the mean PI MoM). HDP included women who developed pre-eclampsia and gestational hypertension. Regression analysis was used to adjust for potential confounders.
Results The analysis included 5887 pregnancies. The incidence of HDP was significantly higher in the group with worsening of the UtA mean PI compared to those without (7.9% versus 5.8%; P < 0.002). Logistic regression analysis demonstrated that both the second trimester UtA PI MoM (OR 8.12, 95% CI 5.07-13.00; P < 0.001) and the difference between the 2 trimesters (OR 3.41, 95% CI 2.434-4.768; P < 0.001) were significant independent predictors for the development of HDP. Methods Subjects from the Exeter Family Study of Childhood Health with maternal fasting plasma glucose (FPG) at 28 weeks of gestation, and fetal DNA from cord blood were studied. A fetal genetic risk score (GRS) for birthweight was calculated using 58 SNPs. The outcomes were corrected birthweight and rates of macrosomia (birthweight >90th centile). Results Maternal FPG and fetal GRS data were available for 679 maternal-offspring pairs. Both maternal FPG and fetal GRS independently predicted birthweight (P < 0.0001 and P = 0.0001, respectively). Fetal GRS did not correlate with maternal FPG (P = 0.83). In the highest tertile for FPG (>4.76 mmol/L), macrosomia rate was higher in the highest fetal GRS tertile (28.6%) than in the lowest GRS tertile (9.3%), P = 0.003. Maternal FPG was positively correlated with cord insulin levels, whilst fetal GRS was not (P < 0.0001 and P = 0.72, respectively). Conclusion Maternal FPG is an accurate predictor of birthweight, but fetal genetics has an independent modifying effect on birthweight and hence macrosomia risk. The impact of fetal genetics is mediated through different mechanisms to maternal glucose, as it does not influence fetal insulin levels. Fetal growth reflects both considerable contributions from maternal glycaemia and fetal genetics, thus reducing the accuracy of prediction of macrosomia based solely on maternal glycaemia.
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Histological and microbiological findings of placentas in early and late preterm births: A casecontrol study Kornete, A 1,2 ; Blazuka, S 3 ; Vedmedovska, N 1,4 ; Sneiders, K Introduction Preterm births occur in approximately 12% of pregnancies worldwide and in 5.6% of pregnancies in Latvia, and the incidence has increased. In almost 30% of cases the clinical cause is not identified. The placenta is a unique and valuable organ in explaining the incomprehensible pathogenesis of prematurity. Methods The retrospective case-control study was conducted to determine placental histological and microbiological findings according to prematurity. Seventy-two placentas, including 17 of early preterm births (22-27 weeks of gestation) and 55 of late preterm births (28-36 weeks of gestation), and 20 placentas of term births (37-41 weeks of gestation) as control group were included in the study. Results Histologic chorioamnionitis was detected more frequently among early preterm births compared with late preterm and term births (P = 0.004). Funisitis and deciduitis were significantly associated with early preterm births (P = 0.001). The most common pathogens included Streptococcus agalactiae, Streptococcus viridans, Staphylococcus epidermidis. Among preterm births maternal placental infarction characterised by massive perivillous fibrin deposition was observed predominantly in early preterm births (P = 0.005). Placental and cord hemorrhagic and thrombotic vasculopathy were more prevalent in late preterm births than early preterm and term births (P = 0.008). Late preterm births placentas revealed degenerative changes and calcification in chorionic villi more often than in early preterm and term births (P = 0.012). Conclusion Comprehension of the pathogenic mechanisms of preterm births, prematurity of the placenta and the impact of placental prematurity on fetal wellbeing may lead to improved early prenatal diagnostic and enhanced preventive care for both the mother and her child.
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Placental histological findings in association with gestational age and neonatal morbidity: A casecontrol study Kornete, A 1,2 ; Blazuka, S 3 ; Vedmedovska, N Introduction Annually one in 10 neonates is born prematurely, and preterm births rates are increasing. Prematurity poses the major challenge for perinatology, accounting for 75% of perinatal mortalities and for 50% of long-term complications. Placental pathology has been implicated in the pathogenesis of adverse fetal outcomes.
Methods Placental histological findings were reviewed in the retrospective case-control study aiming to define correlation between gestational age and neonatal morbidity. Preterm births cohort (N = 72) was subcategorised according to gestational age at the time of birth: extremely (22-27 weeks of gestation), very (28-31 weeks of gestation), moderate to late (32-36 weeks of gestation) preterm. Twenty term births (37-41 weeks of gestation) was selected as controls.
Results Deciduitis was found with a higher frequency among placentas at extremely preterm neonates (P = 0.014). Placentas at very preterm births category more often revealed chorioamnionitis (P = 0.027), chorion-decidual hemorrhage (P = 0.063) and decidual necrosis (P = 0.035). Placental lesions reflecting disturbances of fetal-placental blood flow (villous fibrosis, hyalinisation, calcifications, necrosis, placental thrombotic vasculopathy, cord vessels' thrombosis) were predominantly seen in moderate to late preterm births category (P = 0.014). Funisitis was identified as predictor for the development of intraventricular hemorrhage (P = 0.063). Chorion-decidual hemorrhage and deciduitis were significantly associated with respiratory distress syndrome (P = 0.015). Intrauterine growth restriction was linked to villous edema (P = 0.007). Chorion-decidual hemorrhage was the main predisposing factor for cerebral ischemia (P = 0.016).
Conclusion The placental histological examination may provide a significant impact on care of the premature neonate and insights into future investigations to determine which neonate could be at relatively greater risk for developing long-term complications.
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Outcome of prenatally-diagnosed echogenic fetal lung lesions in the North Mediastinal shift was present in 114 (50%) and hydrops in 21 (9%). Overall survival was 181/187 (97%). 8/21 (38%) of hydropic babies survived, of which 5 underwent antenatal intervention and the remainder regressed spontaneously. Antenatal intervention was performed in 11 (5%). 28/228 (12%) of all babies had postnatal surgery. 4/28 (14%) of the surgical cases were sequestrations and 24/28 (86%) were CCAMs. 18/28 (64%) of children were alive and asymptomatic at most recent follow-up. 2/28 (7%) of babies died, following emergency surgery on day 1 of life. Conclusion The risk of poor outcome in echogenic lung lesions is low. In this series the rate of antenatal and postnatal intervention is lower than is previously reported. Prenatal counselling should reflect this.
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Alternatives to microarrays: Evaluating fetal structural abnormalities using copy number variation by sequencing (CNV-Seq) Walker, L; Cohen, K; Hewitt, S Leeds Teaching Hospitals Trust, Leeds, UK Introduction Prenatal microarray CGH is now widely used to investigate fetal abnormality in centres across the UK. Newer techniques to assess chromosomal variation are based on Next Generation Sequencing and may offer additional benefits. CNVseq is able to detect submicroscopic variants with a similar resolution to array CGH. We present a prospective anonymised cohort study of the comparison of CNV-seq against array CGH for 40 cases of fetal structural abnormality. Methods All fetuses were assessed using 8x 60K oligoarray CGH (BlueGnome) and also by CNV-seq using a ten sample multiplex run on the Illumina HISeq 2500. Array analysis was by BlueFuse software and sequencing bioinformatics were performed by the regional genomic translational unit. Results 40 fetuses were analysed following normal qfPCR. Average resolution in the array group was 80Kb, compared to a mean calculated resolution of 29Kb in the CNV-Seq group. Despite the improved resolution, no additional variants of uncertain significance were identified. 4 significant copy number imbalances were identified with 100% concordance in both groups. Genomic break points were more accurately defined in the CNV-Seq group. Fewer poor quality control scores were obtained in the CNV-Seq group. CNV Seq performed well, even in the presence of low concentration DNA, assessed by Qubit Assay. Conclusion The detection of pathogenic variants is similar between array CGH and CNV-Seq. Poor quantities of prenatal DNA appear to perform better on CNV-seq. There are also improvements in quality control parameters and assessment of genomic breakpoints.
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The introduction of a fetal ultrasound telemedicine service: Quality outcomes and family costs Introduction This study aimed to assess intra-and interobserver agreement for various measurement techniques of the fetal cerebrum, cerebellum and each thalamus in 3D-ultrasonography volumes. Methods 3D-ultrasound volumes were acquired of 78 fetuses at 19-24 weeks of gestational age for a large Dutch cohort study. Measurements were performed offline and independently by two observers using Virtual Organ Computer-Aided AnaLysis in 4D View for volumetry. The intraclass correlation coefficient (ICC) was used for analysis of agreement. Results Intra-and interobserver agreement was excellent for cerebral distance measurement in the form of the occipitofrontal diameter (ICC: 0.881 and 0.912, respectively), as well as total intracranial volume (ICC: 0.961 and 0.866) and the transcerebellar diameter (ICC: 0.909 and 0.842). The rate of agreement was good for cerebellar volumetry (ICC 0837 and 0.721). Agreement for thalamic dimensions varied from poor to fair, scoring lowest in measurement of the anteroposterior diameter (ICC: 0.294 and 0.176) and width (ICC: 0.516 and 0.470), followed by area measurement (ICC 0.460 and 0.543) and with the highest scores in volume calculations (ICC 0.584 and 0.529). Conclusion Agreement for most of the studied fetal cerebral measurements was good to excellent, while some measurements scored poor to fair. Volumetric measurements had higher agreement rates compared to distance measurements of the same structures in all cases, with the exception of the cerebellum. Based on this study, measurements of the intracranial and cerebellar volume in 3D-ultrasonography are feasible for assessment of fetal brain development, while reliability of fetal thalamic measurements remains questionable.
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Reproducibility of a new three-dimensional ultrasound method for the measurement of fetal frontal lobe volume Albers, ME 1 ; Buisman, ET Introduction This study aimed to evaluate intra-and interobserver reproducibility of a new way of measuring frontal lobe volume in three-dimensional ultrasound images of the fetal brain, using virtual organ computer-aided analysis (VOCAL). Methods 3D-ultrasound images of 60 fetuses at 20-24 weeks of gestational age, were randomly selected. Fetal frontal lobe volume was measured offline with the VOCAL method, using the manual mode. Two observers independently measured frontal lobe volume three times per ultrasound. Intra-and interobserver agreement were determined for the first measurement and the average of three measurements, using intraclass correlation coefficients (ICC) and the Bland-Altman method. Results Measurement of the frontal lobe volume was possible in 57 (95%) of the ultrasound volumes. Agreement of the frontal volume measurements was excellent with an intraobserver ICC of 0.78 (95% CI 0.655-0.864) and an interobserver ICC of 0.78 (95% CI 0.582-0.876) for the average of three measurements and an intraobserver ICC of 0.77 (95% CI 0.638-0.858) and an interobserver ICC of 0.77 (95% CI 0.539-0.878) for each observer's first measurement. Bland-Altman analysis shows a mean difference of 672 cm 3 (95% Limits of Agreement (LoA) À5027 to 6370) for intraobserver agreement and of 1338 cm 3 (95% LoA À3880 to 6555) for interobserver agreement. Conclusion The reproducibility of a new way of measuring fetal frontal lobe volume was shown to be excellent. Since agreement is excellent for both the first measurement and the average of three measurements, it is sufficient to measure the frontal lobe volume once.
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Understanding women's experiences of having a small-for-gestational-age fetus Dhillon, S Cytogenetic evaluation of products of conception (POC) for chromosomal abnormalities can determine the cause of pregnancy loss and estbalish risks for future pregnancies. Traditionally, cytogenetic investigation was performed by karyotyping after culture of chorionic villi. Testing by PCR and MLPA has higher success rates and faster reporting times than karyotyping. We aimed to review our numbers of samples, indications for testing, sample failure rates, laboratory reporting times, and cytogenetic results. All samples sent for PCR/MLPA testing from 2013 to 2015 were recorded. Data were collected from laboratory reports and sample tracking books, supplemented by chart reviews. A total of 735 samples were sent for cytogenetic analysis during the three years audited. Of these samples, 677 were successfully processed, giving a 92% success rate. Overall, 49% of processed samples revealed abnormal cytogenetics. Further analysis of the failed samples showed that in 42/58 (72%) only maternal tissue was sent to the laboratory, in 13/58 (22%) the tissue was of insufficient quality for analysis and in only 3 cases did testing fail. The most common indications for testing were recurrent miscarriage (224/735; 30%), and secondtrimester miscarriage (136/735; 18%), however some cases were incorrectly recorded and others sent for inappropriate clinical indications. These data confirm high success rates with the PCR/MLPA technique, and we recommend its continued use as the cytogenetic investigation of choice in pregnancy loss. Local protocols for testing and documentation need to be followed and education may be needed to improve clinical sample collection and processing. Introduction Meconium ileus (MI), neonatal small-bowel obstruction with inspissated meconium most commonly occurs in infants with Cystic Fibrosis (CF). The bowel may be intact, socalled 'simple' MI, or may be compromised in 'complicated' MI. Infants with complicated MI always require surgery. This rare condition has never before been studied on a population basis in the UK. Methods Paediatric surgeons in 26 centres in the UK and Ireland reported cases of MI with CF using an established surveillance system. Data were collected on early management and outcomes prospectively over a two-year period.
Results 56 infants with CF presenting with MI were identified during the data collection period. In 14, there was a suspicion of MI antenatally (25%). The most common feature noted was echogenic bowel, present in 10 (71%) of those identified before birth. Six had bowel dilatation (43%), four had ascites (29%) and one had intra-abdominal calcification (7%). Polyhydramnios was present in 6/54 (11%) of pregnancies. Where the diagnosis was suspected antenatally, parental testing was performed in six, (43% of pregnancies) and fetal DNA testing in three (21%). Antenatal diagnosis was significantly associated with the postnatal finding of complicated MI (P = 0.01). 71% of fetuses suspected antenatally had complicated MI (10/14), and only 31% of those not detected antenatally were complicated (13/42). Conclusion One quarter of cases of MI associated with CF are antentally suspected. These infants are more likely to be complicated and require urgent surgical attention. Close liaison between fetal medicine specialists, neonatologists and paediatric surgeons in such cases is warranted.
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Establishing NIPT as a first choice screening test for Down's syndrome Ajmal-Ali, R; Allen, K; Anderson, P; Jackson, N The Hillingdon Hospital Foundation Trust, London, UK Non Invasive prenatal testing (NIPT) is a new screening test analysing fetal DNA present in maternal circulation, identifying more than 99% of fetuses with T21 (Downs syndrome) 97% with T18 (Edwards syndrome) and 87% with T13 (Patau syndrome). All pregnant women in England are offered screening for Down's Syndrome. Call back groups consist of screen positive results of 1:150 and below, who are then offered diagnostic testing. Currently this comprises of Amniocentesis or Chorionic Venous Sampling which carries an associated risk of 1-2% of miscarriage.
Our aim at The Hillingdon hospital was to explore the option of offering NIPT privately whilst awaiting the decision of the national screening programme. Thus pump priming a fund to allow us to offer NIPT as a second line test free of charge rather than invasive diagnostic testing. Not only has this been a successful introduction to NIPT within our trust, but it has provided a source of income to the maternity department, enabling the test to be offered to all our high risk NHS patients free of charge. This will reduce the amount of invasive testing and associated risk to the unborn child. When this service is commissioned nationally, we will already be up and running and able to provide it immediately, whilst any funds from private testing can be used to invest in other services.
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Neonatal outcome after thoracoamniotic shunting for fetal hydrothorax Witlox, R; Klumper, F; te Pas, A; Oepkes, D; Lopriore, E Leiden University Medical Centre, Leiden, The Netherlands Introduction To evaluate the short-term neonatal outcome after thoracoamniotic shunt placement for fetal hydrothorax. Methods Retrospective evaluation of infants with isolated hydrothorax treated with thoracoamniotic shunt placement at our fetal therapy centre between 2001 and 2016. Results 48 fetuses were treated with a thoracoamniotic shunt. All fetuses had signs of hydrops at the time of intervention. Median (interquartile range (IQR)) gestational age at shunting was 28.7 (24.4-31.3) weeks. Forty-one of 48 (85%) fetuses were born alive at a median (IQR) gestational age of 34.4 (31.1-36.7) weeks. In one child the course of disease after birth was unknown (this child was excluded from further analyses). After birth, 24/40 (60%) children had signs of pleural effusion and 12/40 (30%) needed a thoracic shunt for continuous pleural drainage. Twentyone (53%) children required mechanical ventilation of which 13 (33%) needed high frequency ventilation as rescue therapy. Overall 30/40 (75%) infants survived the neonatal period. Neonatal survival rate was significantly higher when infants were born ≥ 32 weeks of gestation as compared to <32 weeks, 93% (26/28) versus 33% (4/12); P < 0.01). Conclusion The postnatal course of hydropic fetuses treated with thoracoamniotic shunt for isolated hydrothorax is often complicated by respiratory failure and persistent pleural effusions. Neonatal survival is good provided delivery occurs at or after 32 weeks of gestation.
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Evaluation of array comparative genomic hybridisation (aCGH) in prenatal diagnosis Gajewska-Knapik, K 1 ; Staines, J 2 ; Cramer, E 3 ;
Sutton-Cole, A Introduction The advantage of array comparative genomic hybridisation (aCGH) is to detect genomic imbalances, including submicroscopic changes. We report our experience after implementing aCGH on samples from invasive procedures performed for fetal abnormalities including nuchal translucency (NT) >3.5 mm.
Methods Evaluation of aCGH as a diagnostic tool in a Fetal Medicine Department between October 2014 and August 2016.
Results There were 220 aCGH requests for the following indications: high NT (n = 108); structural abnormalities (n = 105, including 3 at feticide); family history of genetic syndrome (n = 5); monochorionic diamniotic twins with high aneuploidy risk (n = 1) and maternal request (n = 1). There were 125 chorionic villus samples (CVS), 92 amniotic fluid (AF), and 3 blood. Subsequently 76 samples were excluded from testing due to: abnormal quantitative fluorescence polymerase chain reaction (QFPCR) result indicating trisomy 13, 18 or 21, Monosomy X or triploidies (n = 72); cystic fibrosis (n = 1); insufficient DNA to process after normal QFPCR result (n = 1); unsuitable DNA (n = 2 blood samples). Array was performed on 144 samples including 6 (4.2%) which required culturing (5 AF and 1 CVS). There were 14 (9.7%) abnormal results. 7 abnormalities classified as microscopically visible and 7 (4.9%) as submicroscopic. 1 submicroscopic abnormality was a parentally derived copy number variation (CNV) of no clinical significance. 5/6 cases of clinically significant submicroscopic abnormalities occurred de novo and 1 CNV was paternally inherited. Conclusion We found aCGH a very efficient and powerful tool in our routine practice. 4.2% of tests enabled identification of clinically relevant submicroscopic abnormalities and 95.8% were successfully performed on uncultured samples. School of Life and Health Sciences, Aston University, Birmingham, UK Introduction TTTS is a complication of monochorionic diamniotic twins with option for treatment via fetoscopic laser ablation (FLA). In the UK, FLA is provided through national referral centres including the service of West Midlands Fetal Medicine Unit (FMU). No national service evaluation exists regarding FLA or other fetal therapy. Aim A qualitative study assessing patient and clinician experience of the service, to determine how to improve care and support. Methods Focus groups with TTTS parents were performed to design the patient questionnaire which was piloted, amended and given in hard copy to every couple attending the FMU for FLA for TTTS from 28/01/16-28/10/16. The clinician questionnaire was piloted locally, amended, and disseminated electronically to clinicians working at FMUs across the UK. Results 13/13 eligible women completed the questionnaire, with median maternal age 28 years (range 20-38), gestational age 20 + 0 weeks (range 16 + 5-23 + 1) and Quintero Stage I n = 2, Stage II n = 3 and Stage III n = 8 at treatment. 32/35 clinician responses were received. Mean service score was 4.900/5 and 4.387/5 by patients and clinicians respectively. Important themes arising were the need for written information regarding TTTS and support groups, difficulty of provision of childcare/ accommodation for family members and the importance for referring centres to emphasise that there may be discrepancies between the potential diagnosis made at the Local Hospital and the FMU. Conclusion This was a small service evaluation and whilst it seems the service is generally well received there are aspects that could be improved. Further evaluation work needs to continue.
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Counselling of triplets: Are we up to date? Spaan, J; Vaikousi, E; Gupta, M; Greco, E; Aquilina, J Royal London Hospital, London, UK Introduction To assess the risk of preterm delivery and perinatal mortality in triplet pregnancies. Methods Retrospective study of triplet pregnancies over a 10-year period (June 2006-June 2016) in a tertiary referral hospital in East London. Results Forty-five triplet pregnancies were reviewed. Median maternal age was 33.2 (AE6.8) years. Eighteen (40%) pregnancies were conceived by in vitro fertilization. 11 (24%) had spontaneous miscarriage and 2 (2%) social termination of pregnancy. Spontaneous reduction to twins or singleton occurred in 8 (18%) cases. Two (2%) women opted for embryo reduction to twins. One pregnancy was lost-to-follow-up. Of the 21 ongoing pregnancies after 12 weeks, 11 were trichorionic triplets and 10 monochorionic twins plus singleton. There were 3 (14%) spontaneous reductions to singleton and 2 (10%) pregnancy losses before 24 weeks of gestation. The median gestational age at delivery was 32 + 5 (IQR 30 + 1-34 + 2) weeks. Early preterm delivery before 32 weeks occurred in 6 (29%) cases, 2 (10%) of which delivered before 28 weeks. Mean birthweight was 1628 g (IQR 1045 (IQR -1948 . There was 1 (5%) neonatal death. The live birth rate of at least one baby was 90%. The live birth ª 2017 The Authors. BJOG An International Journal of Obstetrics and Gynaecology ª 2017 RCOG rate of all three babies was 81%. Overall, the 'take home' rate of three babies was 76%. Conclusion The rate of preterm delivery in triplets remained unchanged in the last 10-years. Future directives Advances in neonatal medicine have significantly improved the outcome of preterm babies. This raises the question of whether embryo-reduction carries the same benefits as it may have 10 years ago.
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Routine third trimester ultrasound scans -can Ireland buck the trend? Smyth, S; Imcha, M University Maternity Hospital Limerick, Limerick, Ireland
Internationally there are conflicting reports on the merits of routine third trimester ultrasound scans (USS) in low risk pregnancies. This study aimed to assess whether routine USS during the third trimester of pregnancy is a valuable resource in low risk pregnancies in Ireland. The routine 31 week USS appointments for January-March 2016 were acquired from the Viewpoint Booking System data. Parameters of fetal growth, anomaly and wellbeing were reviewed. Of the initial 507 records reviewed, 491 were included in the final draft. The USS were at a mean of 31.1 weeks of gestation. The mean estimated fetal weight at the time of the scan was 1.8 kg. This resulted in 46 (9.3%) diagnoses of small-for-gestational-age and 89 (18.1%) diagnoses of large for gestational age. Repeat scans were performed on 260 women who did not originally meet requirements for re-scan. Assessment of growth (n = 150) was the most common reason documented in these cases. In addition to estimating fetal weight, useful parameters such as presentation and markers of fetal wellbeing can be assessed at 31 weeks of gestation. In this low risk population while the prevalence of abnormalities is expectedly low, offering a routine third trimester ultrasound scan allows for identification of evolving high risk pregnancies. This can lead to increased intervention rates and underlines the importance of appropriate interpretation of scan findings by qualified ultrasonographers and fetal medicine specialists. This much debated question of validity of third trimester USS requires more robust studies in Ireland and internationally.
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Patients' views of a fetal ultrasound telemedicine service: A mixed methods evaluation study Lie, M 1 ; Snaith, V 2 ; Bidmead, E 3 ; Marshall, A 3 ;
Robson, SC 1 Introduction The aim of this study was to evaluate from the patient's perspective, a new fetal ultrasound telemedicine service to improve prenatal diagnosis and management at a rural district general hospital.
Methods Eligible patients requiring a specialist fetal medicine consultation were referred to a tertiary care centre for inclusion in the study. Women who underwent a telemedicine examination with a consultant guiding an ultra-sonographer and providing specialist counselling via video-conferencing link were approached to complete a structured questionnaire with the option of participating in a semi-structured telephone interview. The questionnaire included a 5-point scale to evaluate patient satisfaction with the consultation. The mixed methods analysis employed SPSS and Atlas.ti software packages.
Results Of the 80 consultations undertaken during the study, 38 new referrals having their first telemedicine consultation were approached; 31 returned survey questionnaires, and 16 interviewed. Survey and interview participants expressed very high satisfaction with the timely service (93.5 percent highly satisfied with quality of care overall), particularly as a result of the reduced travel times and costs. Analysis of the interviews revealed other advantages such as familiarity and continuity of care from staying local and increased confidence through the sharing of expertise, particularly during an anxious time in their pregnancies. Conclusion A fetal ultrasound telemedicine service was highly acceptable to patients in this rural community, offering them a range of personal benefits as a result of easier access to specialist healthcare.
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Predicting preterm birth in high-risk women with prophylactic intervention in situ: A large prospective series Ross, G; Ridout, A; Seed, P; Shennan, A Results 794 articles were identified and 12 (922 fetuses at risk for CoA) were included. Mean mitral valve diameter z-score was lower (P < 0.001) and the mean tricuspid valve diameter z-score was higher in fetuses with CoA compared to those without CoA (P = 0.01). Mean Aortic valve diameter z-score was lower in fetuses with CoA compared to normal fetuses (P =< 0.001). Mean aortic isthmus diameter z-scores measured either in sagittal (P = 0.02) or in three-vessel trachea view (P < 0.001) were lower in fetuses with CoA. Mean pulmonary artery diameter z-score, the right/left ventricular and pulmonary artery/ascending aorta diameter ratios were higher (P < 0.001, P = 0.02 and P = 0.02) in fetuses with CoA, while aortic isthmus/arterial duct diameter ratio was lower in fetuses with CoA compared to those without (P < 0.001). The presence of coarctation shelf and aortic arch hypoplasia were more common in fetuses with CoA compared to controls (OR: 26.0, 95% CI 4.42-153, P < 0.001 and OR: 38.2, 95% CI 3.01-486, P = 0.005), while persistent left superior vena cava (P = 0.85), ventricular septal defect (P = 0.12) and bicuspid aortic valve (P = 0.14) did not carry an increased risk for this anomaly.
Conclusion The detection rate of CoA may improve when a multiple criteria-prediction model is adopted.
P.FM.72
Two year outcome of pregnancies complicated by low PAPP-A (<0. Universita' degli Studi di Napoli Federico II, Napoli, Italy Introduction The objectives were to determine the relationship between Uterine Artery PI (UtAPI) and Uterine artery volume flow (UtAVF), and also between the maternal Uterine artery volume flow and fetal Umbilical vein volume flow (UVVF). Methods This was a prospective study of 59 low-risk singleton pregnancies between 20 and 24 weeks of gestation. We evaluated fetal venous and arterial Doppler, and Doppler study of the maternal uterine arteries, and the study of calculated UtAVF and UVVF. Diameters of the uterine arteries and umbilical vein were measured. Fetal biometry was measured to calculate estimated fetal weight. Results The mean gestational age was 22.4 weeks. UtAVF was negatively correlated with the ipsilateral UtAPI (r = À0.489, P < 0.01 and, r = À0.411, P < 0.01 for the right and left uterine artery respectively). Total uterine artery volume flow was negatively correlated with sum of the right and the left uterine artery PI. No significant correlation was seen between the total uterine artery flow volume and Umbilical vein volume flow. Conclusion Significant correlation was seen between uterine artery PI and volume flow. Despite the variation in uterine artery volume flow, no significant correlation was seen between the umbilical vein volume flow and uterine artery volume flow.
Compensatory mechanisms must exist to allow enough oxygen delivery to the fetus despite a variation in uterine artery volume flow.
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The influence of gestational age at single fetal loss on the risk of preterm birth in twin pregnancies: Analysis of the STORK multiple pregnancy cohort D'Antonio, F; Thilaganathan, B; Dias, T; Khalil, A Fetal Medicine Unit, Division of Developmental Sciences, St. George's University of London, London, UK Introduction The aim of this study is explore the risk of PTB according to the gestational age at the diagnosis of sIUD. Methods A cohort study of all twin pregnancies from a large regional network of 9 hospitals over a ten-year period. Ultrasound data was matched to hospital delivery records and a mandatory national register for perinatal losses (CMACE). The risk of PTB was stratified according to the gestational age at the diagnosis of sIUD. Results The analysis included 3035 twin pregnancies (2469 dichorionic and 566 MC). The risk of PTB, either before 34 weeks (OR: 10.4, 95% CI 6.4-16.8), before 32 weeks (OR: 8.4, 95% CI 5.2-13.4) or before 28 weeks (OR: 14.0, 95% CI 7.3-26.7) was significantly higher in the pregnancies with sIUD compared to those which were not complicated by any fetal loss. There was a significant trend towards a higher risk of PTB in the pregnancies with sIUD compared to those without (Hazard Ratio 6.50 (95% CI 3.3-12.0)). This trend of higher risk of PTB was seen in both MC and DC twins (P < 0.001 for both). The risk of PTB before 34 weeks was significantly higher (Chi-square test for trend, P < 0.0001) if the sIUD occurred at 20-25 weeks (OR 4.5, 95% CI 1.1-18.9) and 26-32 weeks (OR 37.1, 95% CI 5.9-232.9), when compared to 14-19 weeks of gestation. Conclusion Twin pregnancies complicated by sIUD, regardless of the chorionicity, have a significantly higher risk of PTB before 34, 32 and 28 weeks of gestation.
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Is folic acid supplementation or fortification in pregnancy associated with an increase in multiple births? A systematic review and meta-analysis Lee, A; Hodgetts-Morton, V; Katie Morris, R Results 26 monoamniotic twin pregnancies were identified in the study period. Of these, 5 were conjoined twin pregnancies, but only 1 ended with livebirths, with the remaining pregnancies being terminated. Outcome data were available on 21 of the remaining MCMA pregnancies. In these pregnancies, there were 26 liveborn babies. 15 fetuses (15/42, 35%) were miscarried, and in six pregnancies there were double fetal losses. In the 14 pregnancies with two fetuses alive at 24 weeks, there was only one subsequent fetal loss -a late termination of pregnancy for major brain abnormality (1/28 'potentially viable' fetuses 3.5%). 12 of these pregnancies reached 31 weeks or more before delivery. Conclusion While MCMA pregnancies carry a high risk of fetal loss prior to viability, in pregnancies reaching 24 weeks of gestation, many MCMA twins will have a good pregnancy outcome with appropriate surveillance, and planned preterm delivery. Such data may be helpful in counselling couples after a diagnosis of confirmed monoamniotic twins.
Introduction To develop a tool able to automatically extract bidimensional (2D) fetal head planes from ultrasound tridimensional (3D) volumes. Methods Ultrasound volumes of the fetal brain were acquired at 18-24 weeks of gestation using Philips EPIQ 7G ultrasound system. Acquisition settings included volume box adjustment; single sweep 3D mode; maximum resolution; and 60°acquisition angle. The 'Fetal Brain Plane Finding Prototype' tool (Philips Healthcare) was used to automatically extract 2D transventricular (TV), transthalamic (TT) and transcerebellar (TC) planes. The automatically extracted planes were then assessed and scored for quality by a skilled observer in a blinded fashion. Agreement of the type of plane extracted was assessed between the automated tool and the observer. The image quality was evaluated as 'acceptable' or not for clinical purposes; and scored using predefined criteria (0-5). Results Of the 170 brain volumes acquired, automatic extraction of all three planes was successful in 143 (84%) volumes, giving a total of 429 planes. Of these, 92% were correctly identified as TV, TT or TC and 85% were deemed to be acceptable for clinical purposes. The average score was 4.7. In only 17 planes was the score ≤ 3. Conclusion Automatic extraction of 2D fetal head planes from 3D ultrasound volumes showed good results. This could be used to facilitate and speed up the exam process, while maintaining high specificity and accuracy of the exam. Larger numbers of 3D volumes are needed in order to improve the accuracy of the tool and to validate the technique in clinical practice.
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Ethical issues of non-invasive prenatal testing: Opinions of Dutch healthcare professionals Kater-Kuipers, A; Bunnik, EM Erasmus MC, Rotterdam, The Netherlands Healthcare professionals play a leading role in the implementation of the non-invasive prenatal test (NIPT) in the Netherlands. In contrast to many other countries, the uptake of prenatal screening for Down syndrome is low in the Netherlands: only 25% of pregnant women opt for a prenatal test. It is suggested that NIPT will affect this situation and potentially increase the test uptake. Besides, it is suggested that because of its test characteristics, NIPT will negatively affect the informed decision-making processes of pregnant women. The possibility to expand the scope of NIPT enforces this fear. What do Dutch professionals in the field of prenatal screening think about the possible consequences of NIPT? What do they perceive to be important areas of concern in the implementation of NIPT? In this qualitative study gynaecologists, clinical geneticists, midwives, lab specialists, test developers and policy makers (n = 15) are interviewed about ethical issues surrounding the introduction of NIPT and the expansion of the scope of prenatal screening. In the interviews four ethical themes are discussed: reproductive autonomy, proportionality of NIPT, justice and social aspects. Professionals underlined the importance of reproductive autonomy as the goal of prenatal screening but differed in their opinions on what is considered to be an informed choice. Some professionals focused more on information about the test and medical aspects. Others underlined the importance of personal values and the impact of choice. Opinions also differ about the adequate scope of NIPT, especially when the test is offered as a first-tier prenatal screening test.
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Long-term neurodevelopmental outcome after fetal therapy for congenital lung lesions Witlox, R; Lopriore, E; Klumper, F; Rijken, M; Oepkes, D; van Klink, J Leiden University Medical Center, Leiden, The Netherlands Introduction To evaluate the long-term neurodevelopmental, behavioral and respiratory outcome after fetal therapy for fetal pleural effusion (FPE), congenital cystic adenomatoid malformation (CCAM) and bronchopulmonary sequestration (BPS). Methods Assessment with standardized tests of the long-term outcome in children with primary hydrothorax, CCAM or BPS treated with either thoraco-amniotic shunt placement or laser ablation of the feeding vessel in BPS at our fetal treatment center (Leiden University Medical Center) between January 2001 and May 2016. The primary outcome was a composite outcome termed severe neurodevelopmental impairment (NDI) including cerebral palsy, cognitive or motor test score <70, bilateral blindness and/or deafness. An 'overall adverse outcome' was calculated including perinatal mortality or severe NDI. Results The long-term neurodevelopmental, behavioral and respiratory outcome of long-term survivors treated with fetal therapy for congenital lung lesions at our center between 2001 and 2016 will be presented. Conclusion Overall adverse outcome, including perinatal mortality or severe NDI appears high but is mainly due to a high risk of perinatal death. The risk of severe NDI in long-term survivors is within the range of the incidence of NDI reported in case series treated with other fetal therapies (5-10%). Results are however limited by the relatively small sample size which is inherent with the rarity of the disease and the fetal intervention. To reach reliable conclusions, large multicentre studies including an international web-based registry are warranted to prospectively gather outcome data in this high-risk group of children. Only then, parents can be accurately counselled using not only information on survival, but most importantly also information on long-term development in case of survival.
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Worsening of the uterine artery Doppler is independently associated with fetal cerebral redistribution Monaghan, C Introduction Uterine artery pulsatility index (UtA PI) decreases with advancing gestational age (GA). Previous studies have reported a proportion of pregnancies demonstrate worsening of the UtA Doppler. The aim of this study was to examine the change in the UtA mean PI between the second and third trimester on fetal cerebral redistribution. Methods This cohort study included singleton pregnancies undergoing longitudinal UtA Doppler assessment. Fetal biometry and Dopplers including umbilical artery (UA) and middle cerebral artery (MCA) were recorded. The cerebroplacental ratio (CPR) was determined as the ratio MCA PI/UA PI. The study cohort was divided into two groups according to the change in the UtA Doppler between the two trimesters. Regression analysis was performed to adjust for potential confounders. Results The analysis included 5887 pregnancies. Women who demonstrated a rise in UtA PI had significantly smaller babies (median BW centile 31.60; .09, P < 0.001), significantly higher UA mean PI MoM (median 1.10; IQR 0.98-1.22 versus 1.07; IQR 0.96-1.19, P < 0.001), significantly lower MCA PI MoM (median 0.93; IQR 0.84-1.06 versus 0.95; IQR 0.85-1.07; P < 0.001) and a significantly higher proportion of fetuses with low CPR (7.6% versus 4.2%, P < 0.001). Logistic regression analysis demonstrated that CPR MoM (OR 0.61, CI 0.47-0.79; P < 0.001) and BW centile (OR 0.99, CI 0.99-0.99; P < 0.001) were independently associated with the difference in UtA PI between the second and third trimester. Conclusion Worsening of the UtA Doppler is associated with fetal cerebral redistribution regardless of fetal size.
Introduction NIPT is the most sensitive and specific screening test available for trisomies 13, 18 and 21, but is accessible only to those able to self-fund. In the private sector, especially in cases of self-referral, the quality of counselling is highly variable, and screen positive women are usually referred back to the NHS with little support. Women with fetal abnormalities can therefore access NIPT without referral into fetal medicine, losing opportunities for diagnostic testing and appropriate counselling. Concerns regarding these issues led us to develop a midwife-led NIPT send-away service in partnership with Premaitha Health, providers of the IONA test. We offer a self-pay option on a notfor-profit basis, with all laboratory aspects of the service performed by Premaitha Health. Methods We implemented a midwifery-led standard operating procedure for NIPT in March 2016. Region-wide educational events were arranged for doctors and midwives. Eligibility criteria and pre-test counselling are standardised. Fetal structural anomalies are referred directly to Fetal Medicine. Results 189 IONA tests have been performed since March 2016. Mean result turnaround time 4 days. 5 women (2.6%) screened positive for trisomy 21, and 1 low fetal fraction (0.5%) required a redraw. 30/189 (16%) referrals are from outside LTHT catchment areas. Conclusion Concerns regarding unethical provision of NIPT prompted this development as an alternative to the private sector. Until NIPT becomes available on the NHS for all, there is unavoidable inequality in access. An NHS send-away solution offers an acceptable and cheaper alternative for women who wish a private screening test.
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Fetal biometry and estimated fetal weight in the second trimester: A comparison of intra-and interobserver agreement and variability using ultrasound and magnetic resonance imaging with two-dimensional measurements and threedimensional whole fetal volume techniques Matthew, J Ultrasound derived estimated fetal weight (EFW), can result in significant errors at the extremes of weight ranges, impacting the quality of antenatal care and clinical decision making. Previously, MRI volumetry has been used as a more reliable method of calculating EFW in the third trimester. However, there is a paucity of evidence about the validity of fetal MRI biometry and MRI-derived EFW, especially in mid-pregnancy. 25 fetal studies (mean gestational age, 23.5 weeks), with paired scans, were prospectively collected for common biometric measurements and weight estimation, EFW biometry , obtained by 2 ultrasound and 2 MRI observers. Additionally, 10 cases had an MRI-derived whole fetal volume weight calculated, EFW volume . Between the modalities, there were systematic errors of the biparietal diameter, femur length (FL), and the MRI EFW volume (P < 0.05). MRI was more precise than ultrasound for a number of intraobserver measures (head circumference, abdominal circumference, FL and EFW biometry , P < 0.05), but less precise for some interobserver measures (FL and EFW biometry , P < 0.05). The MRI volume demonstrated excellent intra-and interobserver agreement. Furthermore, the proportion of cases falling outside a AE5% error threshold was; 0% for MRI EFW volume and 22% for US EFW biometry . This study suggests MRI specific growth charts are required, and that MRI has advantages over ultrasound with further gains likely through operator training. Volumetry is reproducible and precise, nonetheless, refinement of the EFW volume equation is required. The findings have important implications for the assessment of fetuses at risk of morbidity and mortality due to early growth disturbances or preterm delivery. Pre-gestational diabetes mellitus (PGDM) is associated with an increased risk of fetal and neonatal morbidity and mortality. The aim of this study was to assess fetal vascular Doppler ultrasound measurements (measured at 30, 33 and 36 gestational weeks) based on glycaemic control in early pregnancy (booking HbA1c). Serial third trimester ultrasound measurements of 231 pregnancies affected with maternal PGDM were analysed; clinical measurements were recorded including measures of glycaemic control (HbA1c). Umbilical Artery Pulsatility Index (UAPI), Middle Cerebral Artery Pulsatility Index (MCAPI) and Middle Cerebral Artery Peak Systolic Velocity (MCAPSV) measurements at 30, 33 and 36 weeks were studied and compared based on booking HbA1c (<6.5% as a marker of 'good glycaemic control' and ≥6.5% as 'poorer control'). Subgroup analysis was performed based on type of PGDM (Type 1 diabetes (T1DM), n = 167; Type 2 diabetes (T2DM), n = 64). There was no consistent pattern of significant differences in UAPI, MCAPI and MCAPSV between groups based on booking glycaemic control. Women with HbA1c >6.5% had a statistically significant increased 33 week MCAPI measurements (MCAPI 'good control' 1.87 AE 0.263; MCAPI 'poorer control' 1.86 AE 0.376; P = 0.02); this difference held in women with T1DM (P < 0.01) but not in T2DM. No consistent pattern has yet been identified in Doppler ultrasound measurements based on booking glycaemic control in PGDM pregnancies. This study is ongoing.
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Quantification of the proteomic signatures underlying human placental vascular maturation Palmowski, P; Zhang, Z; Taggart, J; Robson, S; Treumann, A; Taggart, M Newcastle University, Newcastle upon Tyne, UK Fetal growth is dependent upon the appropriate maturation of the placental vasculature yet the molecular signatures underpinning this process in humans remain unresolved. In an effort to address this, we used a proteome-scale approach (LC-MS-based, label-free quantification of trypsin-treated homogenates using SWATH) to investigate the protein expression changes accompanying placental chorionic plate artery development between 1st (7-12 weeks, n = 9) and 3rd (39-40 weeks, n = 7) trimesters of normal pregnancy (LREC 10/H0906/71). 3586 distinct proteins were quantified on the basis of at least two unique peptides identified per protein. Dynamic regulation of the placental vascular proteome was evident with 1539 proteins differing significantly between 1st and 3rd trimester (t-test with multiple comparison correction, FDR <0.05) and 710 proteins being up-regulated at term. Pathway analysis revealed many notable features to be indicative of vascular maturation. Examples of these were: (1) The down-regulation of molecules key to gene splicing and protein synthesis. These included 41 spliceosome proteins (e.g. topregulated, ACIN1), 68 ribosomal proteins (e.g. RPL10A) and 18 translation initiation/elongation factors (e.g. ELF4A3). (2) The upregulation of components of myofilament/cytoskeletal integrity and metabolic-contraction coupling. These included 31 focal adhesion-related proteins (e.g. FLNA), 13 LIM domain proteins (e.g. PDLIM3) and all elements of the glycolytic cascade (e.g. GP1). Our study gives a comprehensive description of the major protein expression changes, and underlying biological processes, associated with human placental vascular maturation. This also provides a valuable resource to investigate if these features are altered in situations of compromised fetal growth. Supported by a BMFMS bursary.
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Can colour difference on the maternal side of the placenta help distinguish between acute peripartum twin-to-twin transfusion syndrome and twin anaemia polycythaemia sequence? Tollenaar, LSA; Zhao, D; Middeldorp, JM; Slaghekke, F; Oepkes, D; Lopriore, E Leiden University Medical Center, Leiden, The Netherlands Introduction Monochorionic twins share a single placenta and are connected to each other trough vascular anastomoses. Unbalanced inter-twin blood transfusion can lead to various complications, including acute peripartum twin-to-twin transfusion syndrome (acute TTTS) and twin anaemia polycythaemia sequence (TAPS). Acute TTTS and TAPS twins have a similar presentation at birth, but require a different therapeutic approach. A quick and easy tool to distinguish between the two conditions is needed. The objective was to determine the colour intensity difference between two placental shares in monochorionic placentas with acute TTTS and TAPS. Methods We evaluated all digital pictures of TAPS, acute TTTS and a control group of uncomplicated monochorionic placentas examined at our center. We determined the colour intensity of the individual placental share on the maternal side of each monochorionic placenta using an image-processing program and calculated the color difference ratio (CDR). Results Digital pictures of 19 TAPS, 4 acute TTTS and 50 uncomplicated monochorionic placentas were included in this study. A CDR value >1.5 was found in all TAPS placentas and in none of the acute TTTS placentas and uncomplicated monochorionic placentas. Conclusion TAPS placentas have a higher CDR compared to acute TTTS placentas. Examining colour difference between the two placental shares might help distinguish between acute TTTS and TAPS. management has not been determined. The aim of this systematic review was to assess antenatal treatment strategies for FNAIT. Four randomised controlled trials and twenty-three nonrandomised studies were included. Pooling of results was not possible due to considerable heterogeneity. Most studies found comparable outcomes regarding the occurrence of intracranial haemorrhage, regardless of antenatal management strategy applied; FBS, IUPT or IVIG with/without corticosteroids. There is no consistent evidence for the value of adding steroids to IVIG. Fetal blood sampling or intrauterine platelet transfusion resulted in a relatively high complication rate, consisting mainly of preterm emergency caesarean section, 11% per treated pregnancy in all studies combined. Overall, non-invasive management in pregnant mothers who have had a previous neonate with FNAIT is effective without the relatively high rate of adverse outcomes seen with invasive strategies. This systematic review suggests that first line antenatal management in FNAIT is weekly IVIG administration, with or without the addition of corticosteroids.
